Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Soleno Therapeutics (SLNO) Q2 2026 Earnings
SLNO
7
May
Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.45
-0.04
0.38
0.8
Details
Expected EPS
0.68
Actual EPS
0.59
Surprise EPS
-0.09
Surprise Percent
+13.24%
Description
Soleno Therapeutics (SLNO) has reported earnings of 0.59 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login